Tumore al fegato: interventi chirurgici eseguiti in un anno

Indice

• Descrizione indicatore
• Come si legge
• Fonte del dato
• Valutazione istituzionale
• Altre informazioni

Descrizione indicatore

L’indicatore ci consente di calcolare il numero di interventi chirurgici per tumori maligni al fegato eseguiti in un anno in una struttura ospedaliera.
Questo numero rappresenta il "volume" di interventi (indicatore di "volume").

Come si legge

L’indicatore si riferisce al grado di "competenza" e di "sicurezza" delle cure prestate.

Più alto è il numero di interventi chirurgici per tumori maligni al fegato eseguiti in una struttura ospedaliera, maggiore è il grado di esperienza della struttura stessa e la sicurezza del trattamento offerto.

Fonte del dato

Programma Nazionale Esiti 2024.
Confronto tra strutture calcolato su dati 2023.

Nota bene: per tener conto di errori nell’attribuzione di condizioni/interventi a singoli ospedali, sono state escluse dalle analisi tutte le strutture con volumi di attività molto bassi in relazione alla condizione considerata (volume di attività minimo 5 casi/anno).

Valutazione istituzionale

Il Gruppo di lavoro del Programma Nazionale Esiti ha stabilito che un ospedale dovrebbe eseguire almeno 70 interventi all’anno per tumore maligno al fegato.
 
Il semaforo è calcolato sulla base del seguente documento ufficiale:

• Gruppo di lavoro del Programma Nazionale Esiti. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data. Epidemiol Prev. 2017 Sep-Dec;41(5-6 Suppl 2):1-128. doi: 10.19191/EP17.5-6S2.P001.100.

Consulta le strutture sanitarie che effettuano in un anno il maggior numero di interventi chirurgici per tumori al fegato

Altre informazioni

Codici ICD-9-CM selezionati

Criteri di eleggibilità
Sono inclusi tutti i ricoveri, in regime ordinario, con diagnosi principale o secondaria di tumore maligno del fegato (ICD-9-CM 155, 197.7) ed intervento principale o secondario di lobectomia del fegato o epatectomia totale (ICD-9-CM 50.22, 50.25, 50.29, 50.3, 50.4).
Il volume di ricoveri per interventi chirurgici è calcolato su base annuale, riferito all’anno di dimissione del ricovero.

 
Fonti scientifiche

• Richardson AJ, Pang TC, Johnston E, Hollands MJ, Lam VW, Pleass HC. The volume effect in liver surgery - a systematic review and meta-analysis. J Gastroin- test surg 2013;17(11):1984-96. doi: 10.1007/s11605-013-2314-2.
• Garcea G, Breukink SO, Marlow NE et al. A systematic review of the impact of volume of hepatic surgery on patient outcome. surgery 2009;145(5):467-75.
• Gruen RL, Pitt V, Green S, Parkhill A, Campbell D, Jolley D. The effect of provider case volume on cancer mortality: systematic review and meta-analysis. CA Cancer J Clin 2009;59(3):192-211.
• Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg 2005;92(4):389-402.
• Gandjour A, Bannerberg A, Lauterbach KW. Threshold volumes associated with higher survival in health care. Med care 2003;41(10):1129-41.
• Pla R, Pons JMV, Gonzalez JR, Borras JM. Hay niveles assistenciales en cirurgia oncologica? Los que mas hacen, lo hacen mejor? informe sobre la relacion entre volumen de procedimientos y resultados en cirurgia oncologica. Barcelona, Agència d’Avaluaciò de Tecnologia i Recerca Mèdiques, catsalut, Department de sanitat i seguretat social, Generalitat de catalunya, 2003; pp. 1-59.
• Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 2000; 283(9):1159-66.
• Begg cB, cramer ld, hoskins WJ, Brennan Mf. impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280(20):1747-51.
• Bilimoria KY, Bentrem DJ, Feinglass JM et al. Directing surgical quality improve- ment initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J clin oncol 2008;26(28):4626-33.
• Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJ, Stukel tA. Volume and process of care in high-risk cancer surgery. cancer 2006;106(11):2476-81.

• Choti MA, Bowman HM, Pitt HA et al. Should hepatic resections be performed at high-volume referral centers? J Gastrointest surg 1998;2(1):11-20.
• Dimick JB, Cowan JA JR, Knol JA, Upchurch GR JR. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database.Arch surg 2003a;138(2):185-91.

• Dimick JB, Pronovost PJ, Cowan JA JR, Lipsett PA. Postoperative complication rates after hepatic resection in Maryland hospitals. Arch surg 2003b;138(1):41-46.
• Dimick JB, Wainess RM, Cowan JA, Upchurch GR JR, Knol JA, Colletti lM. National trends in the use and outcomes of hepatic resection. J Am coll surg 2004;199(1):31-38.
• Dixon E, Schneeweiss S, Pasieka Jl, Bathe OF, Sutherland F, Doig C. Mortality following liver resection in US medicare patients: does the presence of a liver transplant program affect outcome? J surg oncol 2007;95(3):194-200.
• Eppsteiner RW, Csikesz NG, Simons JP, Tseng Jf, Shah SA. High volume and outcome after liver resection: surgeon or center? J Gastrointest surg 2008;12(10): 1709-16; discussion 1716.
• Figueras J, Busquets J, Ramos E et al. Clinical study of 437 consecutive hepatectomies. Med clin (Barc) 2001;117(2):41-44.
• Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann surg 2005;242(4):540- 44; discussion 544-47.

• Gasper WJ, Glidden dV, Jin c, Way lW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in california made a difference?: A follow-up analysis of another decade. Ann surg 2009;250(3):472-83.
• Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepa- tocellular carcinoma. Arch surg 1999;134(1):30-35.

• Gordon TA, Bowman HM, Bass EB et al. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am coll surg 1999;189(1):46-56.
• Hollenbeck BK, Dunn Rl, Miller DC, Daignault S, Taub DA,Wei JT. Volume-based referral for cancer surgery: informing the debate. J clin oncol 2007;25(1):91-96.
• Lin HC, Lin CC. Surgeon volume is predictive of 5-year survival in patients with hepatocellular carcinoma after resection: a populationbased study. J Gastrointest surg 2009;13(12):2284-91.
• Lin hc, Xirasagar S, Lee HC, Chai CY. Hospital volume and inpatient mortality after cancer-related gastrointestinal resections: the experience of an Asian country. Ann surg oncol 2006;13(9):1182-88.

• Mccoll RJ, You X, Ghali WA, Kaplan G, Myers R, Dixon E. Recent trends of hepatic resection in canada: 1995-2004. J Gastrointest surg 2008;12(11):1839-46; discussion 1846.
• McKay A, You I, Bigam D et al. Impact of surgeon training on outcomes after resective hepatic surgery. Ann surg oncol 2008;15(5):1348-55.
• Nathan H, Cameron Jl, Choti MA, Schulick RD, Pawlik TM. The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and speci city of the relationship. J Am coll surg 2009;208(4):528-38.
• Pal N, Axisa B,Yusof S et al. Volume and outcome for major upper GI surgery in England. J Gastrointest surg 2008;12(2):353-57.

• Simunovic M, Rempel E, Thériault ME et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. can J surg 2006;49(4):251-58.
• Suzuki H, Gotoh M, Sugihara K et al. Nationwide survey and establishment of a clinical database for gastrointestinal surgery in Japan: targeting integration of a cancer registration system and improving the outcome of cancer treatment. Cancer sci 2011;102(1):226-30.
• Wang X, hershman DL, Abrams JA et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J cancer 2007;97(12):1606-12.
• Yasunaga H, Horiguchi H, Matsuda S et al. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese diagnosis Procedure combination database. Hepatol Res 2012;42(11):1073-80.